Please login to the form below

Not currently logged in
Email:
Password:

EFPIA

This page shows the latest EFPIA news and features for those working in and with pharma, biotech and healthcare.

Beneluxa: the future of European market access?

Beneluxa: the future of European market access?

Europe’s industry organisation EFPIA has thrown its weight behind the plans – believing that eliminating unnecessary duplication and creating a single clinical assessment methodology will in fact speed up access, rather

Latest news

More from news
Approximately 32 fully matching, plus 146 partially matching documents found.

Latest Intelligence

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Life science companies, the ABPI and EFPIA have been clear that the UK and the EU need to provide businesses with ‘certainty’ so that they are able to create contingency plans

  • Brexit Means Brexit Brexit Means Brexit

    These common-sense ambitions are broadly aligned with those of EFPIA and pharmaceutical companies across Europe.

  • A quest for innovative solutions A quest for innovative solutions

    Increase returns. UCB is one of the partners in a consortium that includes other EFPIA companies, universities, research organisations, public bodies, non-profit groups and other third parties.

  • Healthcare systems

  • The sound of silence puts the squeeze on generics and biosimilars The sound of silence puts the squeeze on generics and biosimilars

    Fair proposal. He believes lobbying by the European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents 33 national associations and 42 leading pharmaceutical companies, is blocking a revenue stream and ... EFPIA issued a

More from intelligence
Approximately 6 fully matching, plus 27 partially matching documents found.

Latest appointments

  • EFPIA appoints new director general EFPIA appoints new director general

    Joe Jiminez, president of EFPIA, said: “Nathalie has an excellent track record of leadership and engagement across the life science sector. ... We are confident she is the right person to lead EFPIA, working with stakeholders to address the challenges

  • IFPMA appoints director general IFPMA appoints director general

    Thomas Cueni brings expertise from Interpharma and EFPIA. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has selected Thomas Cueni as its new director general. ... Cueni also brings industry expertise from the

  • Bayer appoints president of Americas pharma business Bayer appoints president of Americas pharma business

    He also brings branding and sales leadership experience from Novar tis and Eli Lilly, and recently served as chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan.

  • Eric Cornut appointed EFPIA interim director general Eric Cornut appointed EFPIA interim director general

    Currently an independent consultant based in Basel, Switzerland, Cornut brings over 25 years of pharmaceutical management experience to the role, including five years as chairman of EFPIA's executive committee. ... work. “I am very pleased that Eric

  • EFPIA director general Richard Bergström resigns EFPIA director general Richard Bergström resigns

    Richard Bergström, director general of The European Federation of the Pharmaceutical Industries and Associates (EFPIA), has resigned his post. ... Described by the EFPIA's president Joe Jimenez as “the voice of the pharmaceutical industry in Europe

More from appointments
Approximately 7 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics